MedPath

The efficacy of a moisturizer containing panthenol and bisabolol as an adjuvant therapy for treating mild to moderate chronic hand eczema

Phase 4
Completed
Conditions
Patients with a diagnosis of mild to moderate CHE
moisturizer, panthenol, bisabolol, chronic hand eczema, treatment
Registration Number
TCTR20211130001
Lead Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
56
Inclusion Criteria

1. aged 18 years or older
2. patients with a diagnosis of mild to moderate CHE were included.

Exclusion Criteria

1. patients with severe CHE requiring systemic corticosteroids
2. had disease flare-ups
3. used systemic corticosteroids two weeks prior to the inclusion
4. patients who were pregnant and/or lactating
5. had a history of contact allergy to ingredients in the test product

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The efficacy of a moisturizer containing panthenol and bisabolol baseline, week 2, week 4, week 8, and week 12 The Hand Eczema Severity Index score
Secondary Outcome Measures
NameTimeMethod
The safety of a moisturizer containing panthenol and bisabolol baseline, week 2, week 4, week 8, and week 12 Adverse events,Patient satisfaction week 12 Product satisfaction score
© Copyright 2025. All Rights Reserved by MedPath